Back to search

Alethio Therapeutics Limited

13509030

active
Private Limited Company
Companies House
Health Score
66 / 100

Some Concerns

30/30
Filing
0/30
Financial
36/40
Risk
  • Negative net worth (-10)
  • Current liabilities exceed current assets (-10)
  • 2 outstanding charges (-4)

Details

SOVEREIGN HOUSE, ABINGDON SCIENCE PARK, ABINGDON, OX14 3NB
Incorporated 13/07/2021

Compliance

Accounts

Up to date

Confirmation statement

Up to date

Industry

72110
Research and experimental development on biotechnology

Officers

Dr Bethan Psaila

director · Since 13/07/2021

CLINICIAN SCIENTIST

BRITISH · ENGLAND · Age 47

Also on 1 other board

Mr Mark Throsby

director · Since 13/12/2021

CHIEF OPERATING OFFICER

AUSTRALIAN · NETHERLANDS · Age 59

Dr Sally Marianne Dewhurst

director · Since 03/11/2022

INVESTOR

BRITISH · UNITED KINGDOM · Age 36

Also on 1 other board

Dr Suman Shirodkar

director · Since 01/09/2023

EXECUTIVE

AMERICAN · SWITZERLAND · Age 60

Dr Rohit Batta

director · Since 16/09/2025

CEO

BRITISH · UNITED KINGDOM · Age 49

Mr Michael George Grey

director · Since 16/09/2025

BUSINESS EXECUTIVE

BRITISH · UNITED STATES · Age 73

Persons with Significant Control

Oxford Science Enterprises Plc

50–75% shares
25–50% votes

46, Woodstock Road, Oxford, OX2 6HT

Notified 13/12/2021

Former PSCs

Dr Bethan Psaila

Ceased 13/12/2021

Professor Adam Joseph Mead

Ceased 13/12/2021

Charges2 outstanding

Charge
outstanding

HSBC INNOVATION BANKING

Created 08/11/2023Registered 28/11/2023
Charge
outstanding

HSBC INNOVATION BANKING

Created 08/11/2023Registered 28/11/2023
Charge
satisfied

SILICON VALLEY BANK UK LIMITED

Created 15/03/2023Registered 16/03/2023Satisfied 05/12/2023
Charge
satisfied

SILICON VALLEY BANK UK LIMITED

Created 05/01/2023Registered 09/01/2023Satisfied 05/12/2023
Charge
satisfied

SILICON VALLEY BANK

Created 30/12/2021Registered 06/01/2022Satisfied 10/03/2023

CompanyRankvs 3685+ SIC 72110 peers
20

Financial strength2th percentile among SIC peers · 1/25
Employees22th percentile among SIC peers · 3/15
LiquidityCurrent ratio 0.55× · 6/20
Longevity5 years trading (max 15) · 5/15
Filing complianceAll filings up to date · 15/15
Outstanding charges -10
Show leaderboard
How is this score calculated?
Financial strength1/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees3/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity6/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity5/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Risk deductions

Outstanding charges: -10 pts

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 31/12/2025

Net Worth

-£2.1M

Balance sheet strength

Cash

Cash in the bank

Net Current Assets

-£2.4M

Working capital

Current Assets

£2.9M

Current Liabilities

£5.3M

Fixed Assets

£296k

0avg. employees-7

Balance Sheet

Assets less current liabilities-£2.1M
Prepared with CCH Software

EstimatesDerived

YearCurrent RatioImplied Profit
20250.55-£2.7M
20247.70-£1.9M
20235.19+£1.2M
20226.63

Derived from filed accounts. Not audited figures.